Internal Medicine, Endocrinology, Diabetes, & Metabolism · Woodland Hills, CA
NPI
1093863896
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5601 de Soto Ave
Woodland Hills, CA, 91367
Phone (818) 719-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,753
34 services
Medicare patients, 2024
26
Average age 69
Drug cost, 2024
$881K
4,968 prescriptions
Company payments, 2025
$182
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sima Hassani was code 77080 (standard x-ray), 11 times for 11 patients. In total Sima Hassani billed 34 services in 10 codes, and Medicare paid $1,753.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77080 Standard X-ray | Facility | 11 | 11 | $9.74 | $107 |
By year: 2022 $1,304 for 21 services; 2023 $1,959 for 32 services; 2024 $1,753 for 34 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sima Hassani prescribed most often to Medicare patients was Levothyroxine Sodium, with 946 prescriptions and refills. In total Sima Hassani wrote 4,968 Medicare prescriptions that cost $881K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 946 | 3,030 | 291 | $18K |
| Ozempic Semaglutide | 345 | 354 | 50 | $257K |
| Methimazole Generic | 248 | 813 | 89 | $5,346 |
| Glipizide Generic | 223 | 718 | 74 | $3,544 |
| Metformin Hcl Generic | 215 | 702 | 76 | $3,126 |
| Jardiance Empagliflozin | 172 | 525 | 58 | $114K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 172 | 508 | 70 | $4,544 |
| Liothyronine Sodium Generic | 159 | 508 | 48 | $9,575 |
| Insulin Glargine-Yfgn Generic | 144 | 398 | 63 | $19K |
| Humalog Insulin Lispro | 119 | 346 | 43 | $27K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 107 | 271 | 30 | $28K |
| Atorvastatin Calcium Generic | 105 | 350 | 36 | $1,231 |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 94 | 291 | 39 | $2,805 |
| Metformin Hcl Er Metformin Hcl | 92 | 292 | 33 | $864 |
| Humulin R Insulin Regular, Human | 84 | 225 | 27 | $9,867 |
Brand drugs: 1,485 claims; generic drugs: 3,014 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sima Hassani $182 ($182 in general payments such as food, travel and fees) from 2 companies. The largest payer was Dexcom, Inc. with $158.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.